Postgraduate Course, Parts 1-4: The Future Is Here - Practicing Hepatology in 2024

Nov 15 2024
Convention Center: Hall A: General Session
8:00 AM - 5:30 PM
Ticketed Event
Live Streamed
Captured

World Class Speakers

David E Kaplan, MD, MS, MSc, FAASLD, FACP, AGAF
Presenter

David E Kaplan, MD, MS, MSc, FAASLD, FACP, AGAF

University of Pennsylvania
PJ
Presenter

Pichamol Jirapinyo, MD
Mazen Noureddin, MD, MHSc
Presenter

Mazen Noureddin, MD, MHSc

Houston Methodist Hospital
PP
Presenter

Ponni V. Perumalswami, MD, FAASLD

University of Michigan Medical Center
GI
Presenter

George N. Ioannou, MD, FAASLD

University of Washington Medical Center
Julie Heimbach, MD, FAASLD
Presenter

Julie Heimbach, MD, FAASLD

Mayo Clinic Rochester
RF
Presenter

Richard Finn, MD
LK
Presenter

Laura Kulik

Northwestern Medical Faculty Foundation
Neil Mehta, MD
Presenter

Neil Mehta, MD

University of California, San Francisco
PK
Presenter

Paul Y Kwo, MD, FAASLD

Stanford University Medical Center
Binita M Kamath, MBBChir, FAASLD
Presenter

Binita M Kamath, MBBChir, FAASLD

The Children's Hospital of Philadelphia
Therese Bittermann, MD
Presenter

Therese Bittermann, MD

Perelman School of Medicine
Jordan J. Feld, MD, MPH, FAASLD
Presenter

Jordan J. Feld, MD, MPH, FAASLD

Toronto General Hospital
Ashley Spann, MD, MSACI
Presenter

Ashley Spann, MD, MSACI

Vanderbilt University Medical Center
Salvatore Piano, MD
Presenter

Salvatore Piano, MD

University of Padova
David P Foley, MD, FACS, FAST, FAASLD
Presenter

David P Foley, MD, FACS, FAST, FAASLD

University of Wisconsin School of Medicine and Public Health
Vijay H. Shah, MD, FAASLD
Presenter

Vijay H. Shah, MD, FAASLD

Mayo Clinic Rochester
Mary Rinella, MD, FAASLD
Moderator

Mary Rinella, MD, FAASLD

The University of Chicago
MS
Moderator

Mohammed Siddiqi, MBBS
Anjana Pillai, MD, FAASLD
Moderator

Anjana Pillai, MD, FAASLD

The University of Chicago
Amit G. Singal, MD, MS, FAASLD
Moderator

Amit G. Singal, MD, MS, FAASLD

UT Southwestern Medical Center
Jorge Bezerra, MD, FAASLD
Moderator

Jorge Bezerra, MD, FAASLD

University of Texas Southwestern Medical Center
Oren K Fix, MD, MSc, FAASLD
Moderator

Oren K Fix, MD, MSc, FAASLD

University of North Carolina at Chapel Hill

Description

With rapid advancements in digital health, big data, and artificial intelligence, the practice of hepatology is undergoing a transformative evolution. This 4-session course provides comprehensive updates on crucially important diagnostics and therapeutics as they relate to persons with liver disease with a focus on innovation and changing paradigms. Each session is practical and interactive, featuring 4 lectures followed by a question-and-answer discussion with the panel.
 
Session 1 (8:00 AM - 9:30 AM): A Day in the Life of the Modern Hepatologist—Steatotic Liver Diseases
This session addresses the most common liver diseases: metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD). Speakers address how to risk-stratify persons with MASLD using modern techniques available now or in the future. Presenters also discuss practical approaches to MASLD treatment, including both approved and pipeline therapeutics, along with novel treatments for obesity, including pharmaceutical, surgical, and endoscopic interventions. The changing role of hepatology clinicians and practical approaches for the treatment of alcohol use disorders are also explored.

Session 2 (11:00 AM - 12:30 PM): Liver Cancers—New Solutions for Old Problems
Primary liver cancer remains one of the most lethal cancers worldwide. However, new hope arises from novel methods for risk stratification and treatment. This session reviews novel methods for risk stratification and surveillance, including electronic health record (EHR) risk stratification, novel imaging biomarkers, and new imaging modalities. Evolving paradigms for cholangiocarcinoma are addressed along with new treatments for HCC. The role of hepatology specialists in systemic therapy is also debated.

Session 3 (2:00 AM - 3:30 PM): Updates for the Liver Clinic in 2024
This session covers new developments in hereditary liver diseases, pediatric liver diseases, autoimmune liver diseases, and viral hepatitis. Topics addressed include new developments in Wilson disease, hemochromatosis, and alpha-1 antitrypsin deficiency; pediatric liver diseases updates; new developments in autoimmune liver diseases; and future directions for HBV/HDV coinfection therapy.
 
Session 4 (4:00 PM - 5:30 PM): Paradigm Shifts in Hepatology
Focusing on paradigm shifts in the care of persons with liver disease, this session explores the use of digital information to improve health disparities, changing approaches to portal hypertension treatment, and new technological advances to enhance the organ donor pool. The session concludes with a keynote lecture addressing how to harness the potential of our digital future.

Journey Maps

Objectives

  • Review current strategies for treating patients with MASLD and alcohol use disorder.
  • Describe novel approaches to managing patients with liver cancers.
  • Discuss recent developments in hereditary, pediatric, and autoimmune liver diseases, as well as viral hepatitis.
  • Identify uses of digital information and new technologies to improve care for patients with liver disease, including its use to address health disparities.
Chair

Grace Su, MD, FAASLD

University of Michigan Medical Center
Chair

Hugo E. Vargas, MD, FAASLD

Mayo Clinic Arizona
Chair

Marina Serper, MD, MS

University of Pennsylvania Health System